2013
DOI: 10.2174/2210289201304010031
|View full text |Cite
|
Sign up to set email alerts
|

Cholinesterase Enzymes Inhibitory Activities of Methanolic and Aqueous Extracts of Different Parts of

Abstract: In this study was found that inflammation in interstitial lung tissue of mice C57Bl/6 after intratracheal injection of the bleomycin is accompanied by the increase of the bone marrow and circulating blood cells with the phenotype (CD3, CD45R (B220), Ly6C, Ly6G (Gr1), CD11b (Mac1), TER-119), Sca-1 + , c-Kit + , CD34 -(hematopoietic stem cells (HSCs)) and hematopoietic progenitor cells (granulocyte-erythroid-macrophage-megakaryocytic (CFU-GEMM) and granulocyte precursors (CFU-G)). These results demonstrate that … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(1 citation statement)
references
References 45 publications
0
1
0
Order By: Relevance
“…This compound will inhibit the hypoxia-inducible factor 1 (HIF-1) signaling pathway which is the pathway for angiogenesis stimulation (64). Reserpine also demonstrated the anti-fibrotic and anti-inflammatory activity of the compounds present in MOSEIL, this compound will prevent the formation of fibroblast cells by inhibiting the differentiation of mesenchymal stromal cells (MSCs) (65). After the active compounds MOSEIL and MOLP are molecularly docked with the same target protein, namely TGF-β1, both can be known to cause cancer cells.…”
Section: Molecular Docking Analysis and Visualization Of Molp And Moseilmentioning
confidence: 98%
“…This compound will inhibit the hypoxia-inducible factor 1 (HIF-1) signaling pathway which is the pathway for angiogenesis stimulation (64). Reserpine also demonstrated the anti-fibrotic and anti-inflammatory activity of the compounds present in MOSEIL, this compound will prevent the formation of fibroblast cells by inhibiting the differentiation of mesenchymal stromal cells (MSCs) (65). After the active compounds MOSEIL and MOLP are molecularly docked with the same target protein, namely TGF-β1, both can be known to cause cancer cells.…”
Section: Molecular Docking Analysis and Visualization Of Molp And Moseilmentioning
confidence: 98%